Endocrinology Emergency Medicine Strong — JBDS 2023 Guideline
DKA Severity Classification
Classifies diabetic ketoacidosis severity using pH, bicarbonate, and blood ketone levels.
References
- Joint British Diabetes Societies (JBDS) Inpatient Care Group. Management of Diabetic Ketoacidosis in Adults. 2023.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Sodium Bicarbonate · Alkalising Agent / Electrolyte
- Insulin (IV Infusion — ICU Glucose Control) · Insulin — ICU Glucose Management
- Sodium Bicarbonate 8.4% · Electrolyte Buffer
- Sodium bicarbonate with sodium chloride · Alkalinising IV solution
- Insulin (Soluble / Actrapid) · Insulin
- Insulin Glargine · Long-Acting Insulin Analogue (Basal)
Pathways
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016
- Pituitary Apoplexy · ENEA 2011 / Pituitary Society
- Hypercalcaemia Management · NICE / Endocrine Society
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.